SC 13G/A

SCHEDULE 13G HOLDINGS REPORT AMENDMENT

Company: IOVANCE BIOTHERAPEUTICS, INC.
Filed: February 13, 2019
Accession Number: 0001172661-19-000439

View Document ↗ View on SEC.gov ↗